• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “presence-capital” Archives

          in
          Entry Author Date Location
          Presence Capital Takes the Temperature of VR/AR at Mid-Year Bernadette Tansey 08/07/17 San Francisco
          VR Startup Visbit Adds Support for Game Site Unity, and a Web Player Bernadette Tansey 07/26/17 San Francisco
          Uru Garners $800,000 Seed Financing VentureDeal 01/03/17 New York
          STRIVR Labs Lands $5,000,000 Series A Round VentureDeal 12/15/16 San Francisco
          Visbit Raises $3.2M Seed Round To Smooth Choppy VR Streaming Bernadette Tansey 12/07/16 San Francisco
          Visbit Obtains $3,200,000 Seed Funding Round VentureDeal 12/07/16 San Francisco
          Roundup: Owlchemy, TheWaveVR, Fe3 Medical, & Rackspace Buyout? Angela Shah 08/09/16 Texas
          TheWaveVR Secures $2,500,000 Seed Financing Round VentureDeal 08/08/16 Texas
          Seeking to Bring Concerts Into the Virtual World, WaveVR Raises $2.5M Angela Shah 08/05/16 Texas
          Scope AR Garners $2,000,000 New Financing Round VentureDeal 07/18/16 San Francisco
          Scope AR Lands $2,000,000 Seed Round VentureDeal 07/15/16 San Francisco
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

            Sponsored · Special Report

            As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

            Hyperinflation in rents is over

            Hughes Marino
          • The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Sponsored · Whitepaper

            The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars

            IBM Watson
          • Xcelerating Life Sciences San Francisco: The Highlights Podcast

            From Our Editors · Podcast

            Xcelerating Life Sciences San Francisco: The Highlights Podcast

            The AI, Big Data, and R&D Boom

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.